Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623794 | SCV000741084 | pathogenic | Inborn genetic diseases | 2015-10-23 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV004576959 | SCV005061186 | likely pathogenic | Microcephaly 2, primary, autosomal recessive, with or without cortical malformations | criteria provided, single submitter | clinical testing | The observed stop gained c.2575C>T(p.Gln859Ter) variant in WDR62 gene has not been reported previously as a pathogenic variant nor a benign variant, to our knowledge. The c.2575C>T variant is absent in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic. The nucleotide change c.2575C>T in WDR62 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Computational evidence (MutationTaster - Disease causing) predicts a damaging effect on protein structure and function for this variant. This sequence change creates a premature translational stop signal (p.Gln859Ter) in the WDR62 gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. In absence of another reportable variant in WDR62 gene, the molecular diagnosis is not confirmed. |